ReviewInternational journal of environmental research and public health2021

Whether Prolyl Hydroxylase Blocker-Roxadustat-In the Treatment of Anemia in Patients with Chronic Kidney Disease Is the Future?

Władysław Grzeszczak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.